Glycorex Transplantation AB (NGM:GTAB B) Marketable Securities : kr0.97 Mil (As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Glycorex Transplantation AB's Marketable Securities for the quarter that ended in Mar. 2025 was kr0.97 Mil.

Glycorex Transplantation AB's annual Marketable Securities increased from Dec. 2022 (kr0.93 Mil) to Dec. 2023 (kr0.97 Mil) and increased from Dec. 2023 (kr0.97 Mil) to Dec. 2024 (kr0.99 Mil).

Glycorex Transplantation AB Marketable Securities Historical Data

The historical data trend for Glycorex Transplantation AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Marketable Securities Chart

Glycorex Transplantation AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

0.96

0.95

0.93

0.97

0.99

Glycorex Transplantation AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															0.96	0.97	0.98	0.99	0.97

Glycorex Transplantation AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Glycorex Transplantation AB (NGM:GTAB B) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Glycorex Transplantation AB Marketable Securities Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Glycorex Transplantation AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

O33:Germany

Address

Solvegatan 41, Lund, SWE, 223 70

Website

http://www.glycorex.se

Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines